A study done by Blaheta et al. on the prostate cancer cell model (PC3) demonstrated that HCMV acts on the invasive properties of the prostatic cancerous cell line PC3, and this carcinogenic process is promoted by elevated c-Myc levels [81]. This evidence concerns the gene MYC and prostate carcinoma.